The term LOC643909 Inhibitors identifies a specific class of chemical compounds strategically designed to modulate the activity of LOC643909, a molecular target currently under scientific investigation. These inhibitors are meticulously crafted through principles rooted in medicinal chemistry, with a primary focus on selectively interfering with the normal functions of LOC643909 within cellular processes. The structural features of LOC643909 Inhibitors undergo a rigorous optimization process, often incorporating computational modeling and structure-activity relationship studies, to ensure their molecular configurations are precisely tuned for effective binding to the target.
The significance of LOC643909 Inhibitors lies in their potential to disrupt the biochemical activities associated with LOC643909, a molecular entity believed to play a role in various biological pathways. Researchers in this field delve into the three-dimensional structure of LOC643909 and its binding interactions with inhibitors, aiming to unravel the intricate molecular mechanisms underlying inhibition. The study of LOC643909 Inhibitors contributes to a broader understanding of cellular processes, offering insights into the roles played by LOC643909 in diverse biological pathways and expanding our knowledge of the regulatory networks governing cellular activities. This research not only advances our comprehension of the molecular intricacies surrounding LOC643909 but also contributes to the broader scientific understanding of molecular targets and their involvement in fundamental cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
By inhibiting CDKs, these compounds could indirectly affect proteins like Speedy/RINGO that act as CDK activators. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
These compounds prevent the degradation of proteins by the proteasome, potentially leading to reduced expression of proteins through feedback inhibition. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
Hsp90 is involved in the proper folding of many proteins. Inhibiting Hsp90 can result in the degradation of its client proteins, which might include Speedy/RINGO proteins. | ||||||
BML-277 | 516480-79-8 | sc-200700 sc-200700A | 10 mg 50 mg | $132.00 $492.00 | 2 | |
As Speedy/RINGO proteins are involved in cell cycle checkpoints, inhibitors of checkpoint kinases could disrupt their function. | ||||||
PHA-848125 | 802539-81-7 | sc-364581 sc-364581A | 5 mg 10 mg | $304.00 $555.00 | ||
Polo-like kinases play roles in cell cycle progression. Inhibiting them could interfere with Speedy/RINGO protein functions. | ||||||
Thymidine | 50-89-5 | sc-296542 sc-296542A sc-296542C sc-296542D sc-296542E sc-296542B | 1 g 5 g 100 g 250 g 1 kg 25 g | $49.00 $73.00 $270.00 $458.00 $1758.00 $114.00 | 16 | |
These analogues can be incorporated into RNA, potentially affecting mRNA stability and translation efficiency. | ||||||
Vinblastine Sulfate | 143-67-9 | sc-201447 sc-201447A sc-201447B sc-201447C | 10 mg 50 mg 100 mg 1 g | $109.00 $412.00 $561.00 $2244.00 | 9 | |
By disrupting microtubule dynamics, these compounds can arrest cells in specific cell cycle phases, potentially influencing Speedy/RINGO activity. | ||||||